Placebos in clinical practice and research

被引:38
作者
DeDeyn, PP
DHooge, R
机构
[1] UNIV ANTWERP, LAB NEUROCHEM & BEHAV, B-2020 ANTWERP, BELGIUM
[2] MIDDELHEIM HOSP, DEPT NEUROL, ANTWERP, BELGIUM
关键词
medical ethics; placebo; research; epilepsy; Alzheimer's disease; deontology;
D O I
10.1136/jme.22.3.140
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The main current application of placebo is in clinical research. The term placebo effect refers to diverse non-specific, desires or non-desired effects of substances or procedures and interactions between patient and therapist. Unpredictability of the placebo effect necessitates placebo-controlled designs for most trials. Therapeutic and diagnostic use of placebo is ethically acceptable only in few well-defined cases. While ''therapeutic'' application of placebo almost invariably implies deception, this is not the case for its use in research. Conflicts may exit between the therapist's Hippocratic and scientific obligations. The authors provide examples in neuropsychiatry, illustrating that objective scientific data and well-considered guidelines may solve the ethical dilemma. Placebo control might even be considered and ethical obligation but some previous should be kept in mind: (a) no adequate therapy for the disease should exist and/or (presumed) active therapy should have serious side-effects; (b) placebo treatment should not last too long; (c) placebo treatment should not inflict unacceptable risks, and (d) the experimental subject should be adequately informed and informed consent given.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 39 条
[1]  
BATTEZZATI M, 1995, MINERVA MED, V46, P1178
[2]   PROGNOSIS OF EPILEPSY IN NEWLY REFERRED PATIENTS - A MULTICENTER PROSPECTIVE-STUDY [J].
BEGHI, E ;
TOGNONI, G .
EPILEPSIA, 1988, 29 (03) :236-243
[3]   FELBAMATE - A DOUBLE-BLIND CONTROLLED TRIAL IN PATIENTS UNDERGOING PRESURGICAL EVALUATION OF PARTIAL SEIZURES [J].
BOURGEOIS, B ;
LEPPIK, IE ;
SACKELLARES, JC ;
LAXER, K ;
LESSER, R ;
MESSENHEIMER, JA ;
KRAMER, LD ;
KAMIN, M ;
ROSENBERG, A .
NEUROLOGY, 1993, 43 (04) :693-696
[4]  
BREWIN TB, 1982, LANCET, V2, P919
[5]  
BRILL I C, 1958, Northwest Med, V57, P483
[6]  
BROWN WA, 1994, NEUROPSYCHOPHARMACOL, V10, P265, DOI 10.1038/npp.1994.53
[7]  
BROWN WA, 1988, PSYCHOPHARMACOL BULL, V24, P14
[8]   AN EVALUATION OF INTERNAL-MAMMARY-ARTERY LIGATION BY A DOUBLE-BLIND TECHNIC [J].
COBB, LA ;
THOMAS, GI ;
DILLARD, DH ;
MERENDINO, KA ;
BRUCE, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1959, 260 (22) :1115-1118
[9]   DOES SHORT-TERM PLACEBO-TREATMENT OF CHRONIC-SCHIZOPHRENIA PRODUCE LONG-TERM HARM [J].
CURSON, DA ;
HIRSCH, SR ;
PLATT, SD ;
BAMBER, RW ;
BARNES, TRE .
BRITISH MEDICAL JOURNAL, 1986, 293 (6549) :726-728
[10]  
DELAY J, 1973, MED PSYCHOL